Illumiscreen uses whole-genome sequencing (WGS) technology to provide accurate non-invasive prenatal screening results.
Illumiscreen combines low failure rates, highly accurate results, and low false-positive rates, making it one of the most reliable non-invasive prenatal screens available. More information is available in the resources section of our website.
Illumiscreen uses an algorithm to increase the specific signal of aneuploid chromosomes and hence to improve the overall accuracy of classifying affected samples.
The test output further provides unambiguous results, not a risk score and is not dependent on maternal age, maternal weight, gestational age (after 10 weeks) or ethnicity.
In addition, it does not carry the risk of complications that invasive procedures do.
